Search
Search Funnelback University
Your query has been expanded to `All News` |u:www.enterprize.cam.ac.uk. Search for `All News` |u:www.enterprise.cam.ac.uk instead.
1 -
42 of
42
search results for `All News` |u:www.enterprise.cam.ac.uk or `All News` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Latest news, case studies and blogs – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/latest-news/11 Apr 2024: Filter by:. All Post Types. Insight. Case Studies. News. Videos. All Categories. ... Social Ventures. Software Tools. Spin-outs. Technology Transfer. TenU. Uncategorised. Ventures. All Years.
-
embryos Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/embryos/feed/12 Jul 2024: aneuploidy blastocyst BlueGnome embryos IVF nick haan pregnancy https://camenterprise.dev.twkmedia.com/news/2012/5/bluegnome-technology-shown-increase-ivf-success-ra/ pAround half of all human embryos stop developing ... pAround half of all human embryos -
https://www.enterprise.cam.ac.uk/wp-json/wp/v2/posts/5341
https://www.enterprise.cam.ac.uk/wp-json/wp/v2/posts/5341tried them all), the news represents an interesting development in the use of gene therapy and healthcare as a whole. -
APC Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/apc/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
Medicxi Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/medicxi/feed/12 Jul 2024: might one day help all patients with haemophilia, including those whobecome resistant to existing therapies, has been developed./p pThe post a ... They suggest this treatment could one day help all patients with haemophilia, including those who develop -
Dr Andy Richards Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/dr-andy-richards/feed/12 Jul 2024: cam.ac.uk/news/spin-out-qkine-secures-additional-550k/ Catherine Aman Mon, 03 Jun 2019 07:00:08 0000 Life Sciences Spin-outs Technology Transfer Dr Andy Richards Dr Catherine ... Cambridge Enterprise led the £550k funding round, which was joined by five -
Versius Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/versius/feed/12 Jul 2024: cam.ac.uk/news/sister-organisation-cic-participates-in-195-million-series-c-financing-for-cmr-surgical/ Catherine Aman Tue, 17 Sep 2019 14:19:46 0000 Cambridge Innovation Capital CIC ... Versius system is a four-axis wrist joint incorporated within all -
Jim Warwick Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/jim-warwick/feed/12 Jul 2024: cam.ac.uk/news/spin-out-qkine-secures-additional-550k/ Catherine Aman Mon, 03 Jun 2019 07:00:08 0000 Life Sciences Spin-outs Technology Transfer Dr Andy Richards Dr Catherine ... Cambridge Enterprise led the £550k funding round, which was joined by five -
Qkine Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/qkine/feed/12 Jul 2024: cam.ac.uk/news/cambridge-spin-out-qkine-secures-1-5m-series-a-funding-to-accelerate-global-scale-up/ TWK Media Mon, 08 Jun 2020 16:15:47 0000 Life Sciences ... Cambridge Enterprise led the £550k funding round, which was joined by five angel -
pregnancy Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/pregnancy/feed/12 Jul 2024: aneuploidy blastocyst BlueGnome embryos IVF nick haan pregnancy https://camenterprise.dev.twkmedia.com/news/2012/5/bluegnome-technology-shown-increase-ivf-success-ra/ pAround half of all human embryos stop developing ... pAround half of all human embryos -
Blood Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/blood/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
CMR Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/cmr/feed/12 Jul 2024: Versius system is a four-axis wrist joint incorporated within all the robotic arms. ... type=news&p=6909 pCambridge Medical Robotics, which is developing robot-assisted surgery technology,today announced it has secured $20.3 million in a Series A funding. -
Dr Catherine Elton Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/dr-catherine-elton/feed/12 Jul 2024: cam.ac.uk/news/spin-out-qkine-secures-additional-550k/ Catherine Aman Mon, 03 Jun 2019 07:00:08 0000 Life Sciences Spin-outs Technology Transfer Dr Andy Richards Dr Catherine ... Cambridge Enterprise led the £550k funding round, which was joined by five -
Hidde-Jan (HJ) Lemstra Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/hidde-jan-hj-lemstra/feed/12 Jul 2024: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
haemophilia Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/haemophilia/feed/12 Jul 2024: This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. ... They suggest this treatment could one day help all patients with haemophilia, including those who -
gene therapy Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/gene-therapy/feed/12 Jul 2024: cam.ac.uk/news/switching-on-a-key-cancer-gene-could-provide-first-curative-treatment-for-heart-disease/ Catherine Aman Wed, 15 Apr 2020 11:51:53 0000 Life Sciences ... up with spectacular puns: ‘far sighted investors back glaucoma therapy company’ -
https://www.enterprise.cam.ac.uk/wp-json/wp/v2/posts/6133
https://www.enterprise.cam.ac.uk/wp-json/wp/v2/posts/6133This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
24sure Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/24sure/feed/12 Jul 2024: aneuploidy blastocyst BlueGnome embryos IVF nick haan pregnancy https://camenterprise.dev.twkmedia.com/news/2012/5/bluegnome-technology-shown-increase-ivf-success-ra/ pAround half of all human embryos stop developing ... pAround half of all human embryos -
aneuploidy Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/aneuploidy/feed/12 Jul 2024: aneuploidy blastocyst BlueGnome embryos IVF nick haan pregnancy https://camenterprise.dev.twkmedia.com/news/2012/5/bluegnome-technology-shown-increase-ivf-success-ra/ pAround half of all human embryos stop developing ... pAround half of all human embryos -
serpin Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/serpin/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
Quethera: A new vision for gene therapy – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/blog-quethera-a-new-vision-for-gene-therapy/21 Sep 2015: tried them all), the news represents an interesting development in the use of gene therapy and healthcare as a whole.
-
Dr David Ayala Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/dr-david-ayala/feed/12 Jul 2024: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
Professor Julian Allwood Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/professor-julian-allwood/feed/12 Jul 2024: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
thrombin Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/thrombin/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
Dr Marko Hyvönen Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/dr-marko-hyvonen/feed/12 Jul 2024: cam.ac.uk/news/spin-out-qkine-secures-additional-550k/ Catherine Aman Mon, 03 Jun 2019 07:00:08 0000 Life Sciences Spin-outs Technology Transfer Dr Andy Richards Dr Catherine ... Cambridge Enterprise led the £550k funding round, which was joined by five -
blastocyst Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/blastocyst/feed/12 Jul 2024: aneuploidy blastocyst BlueGnome embryos IVF nick haan pregnancy https://camenterprise.dev.twkmedia.com/news/2012/5/bluegnome-technology-shown-increase-ivf-success-ra/ pAround half of all human embryos stop developing ... pAround half of all human embryos -
Glaucoma Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/glaucoma/feed/12 Jul 2024: Kenji Yasukawa Quethera rAAV retinal ganglion cells https://camenterprise.dev.twkmedia.com/?post_type=news&p=11259 pAstellas Pharma Inc. ... sighted investors back glaucoma therapy company’ and the very popular ‘investors set their sights on -
Reduse is writing the story of unprinting – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/from-academic-discovery-to-successful-business-reduse-is-writing-the-story-of-unprinting/1 Feb 2016: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea.
-
IVF Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/ivf/feed/12 Jul 2024: pAround half of all human embryos stop developing before the blastocyst stage at day five of development. ... However, around half of all human embryos stop developing before the blastocyst stage at day five of development. -
American Society of Hematology Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/american-society-of-hematology/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
Professor Arthur Schawlow Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/professor-arthur-schawlow/feed/12 Jul 2024: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
Reduse Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/reduse/feed/12 Jul 2024: This paper triggered a media buzz in early 2012, being picked up by the New Scientist, BBC News, and the Telegraph, among others. ... And all this attention unlocked something in David’s and Julian’s minds regarding the value of their idea. -
ApcinteX Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/apcintex/feed/12 Jul 2024: com/?post_type=news&p=7455 pA new treatment that might one day help all patients with haemophilia, including those whobecome resistant to existing therapies, has been developed./p pThe post ... They suggest this treatment could one day help all patients -
Addenbrooke's hospital Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/addenbrookes-hospital/feed/12 Jul 2024: that might one day help all patients with haemophilia, including those whobecome resistant to existing therapies, has been developed./p pThe post a ... They suggest this treatment could one day help all patients with haemophilia, including those who -
nick haan Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/nick-haan/feed/12 Jul 2024: all human embryos stop developing before the blastocyst stage at day five of development. ... pAround half of all human embryos stop developing before the blastocyst stage at day five of development. -
Trevor Baglin Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/trevor-baglin/feed/12 Jul 2024: This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. ... They suggest this treatment could one day help all patients with haemophilia, including those who -
Quethera Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/quethera/feed/12 Jul 2024: Kenji Yasukawa Quethera rAAV retinal ganglion cells https://camenterprise.dev.twkmedia.com/?post_type=news&p=11259 pAstellas Pharma Inc. ... on glaucoma’ (trust me, we’ve tried them all), the news represents an interesting development in the use of -
Cambridge Medical Robotics Ltd Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/cambridge-medical-robotics-ltd/feed/12 Jul 2024: Versius system is a four-axis wrist joint incorporated within all the robotic arms. ... type=news&p=6909 pCambridge Medical Robotics, which is developing robot-assisted surgery technology,today announced it has secured $20.3 million in a Series A funding. -
cambridge university hospitals Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/cambridge-university-hospitals/feed/12 Jul 2024: cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/ Catherine Aman Thu, 27 Oct 2016 09:00:04 0000 Life Sciences Spin-outs Technology Transfer Addenbrooke's hospital ... They suggest this treatment could one day help all -
Cambridge Institute for Medical Research Archives – Cambridge…
https://www.enterprise.cam.ac.uk/tag/cambridge-institute-for-medical-research/feed/12 Jul 2024: cam.ac.uk/news/cambridge-spin-out-doses-first-subject-with-treatment-for-alpha-1-antitrypsin-deficiency/ TWK Media Wed, 19 Aug 2020 08:29:44 0000 Life Sciences Spin-outs ... They suggest this treatment could one day help all patients with haemophilia, -
Jim Huntington Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/jim-huntington/feed/12 Jul 2024: This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. ... They suggest this treatment could one day help all patients with haemophilia, including those who -
BlueGnome Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/bluegnome/feed/12 Jul 2024: all human embryos stop developing before the blastocyst stage at day five of development. ... pAround half of all human embryos stop developing before the blastocyst stage at day five of development.
Refine your results
Date
- 38 Past 6 months
- 38 2024
- 38 Past year
- 37 Past 3 months
- 37 Past fortnight
- 37 Past month
- 37 Past week
- 2 Uncertain
- 1 2016
- 1 2015
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.